Cetero Research

 

Today's Research for Tomorrow's Healthcare
 
 
+
+
+
 +
+
 
   
     
 
Complete Validated Assays
Available assay list  
Method development and validation  
LC/MS/MS  
Immunochemistry  




  Compound Matrix Sensitivity Methodology
Ofloxacin Plasma 50.0 ng/mL HPLC/FLD
Olanzapine Plasma 0.100 ng/mL LC/MS/MS
Olmesartan Plasma 10.0 ng/mL LC/MS/MS
Olsalazine Plasma 2.00 ng/mL LC/MS/MS
Omeprazole Plasma 2.00 ng/mL LC/MS/MS
Ondansetron Plasma 0.500 ng/mL LC/MS/MS
Orphenadrine Plasma 2.00 ng/mL HPLC
Oxandrolone Plasma 0.250 ng/mL LC/MS/MS
Oxaprozin Plasma 1.00 µg/mL HPLC
Oxcarbazepine / Hydroxyoxcarbazepine Plasma 0.00500 / 0.0500 µg/mL LC/MS/MS
Oxybutynin / N-Desethyloxybutynin Plasma 0.100 / 0.200 ng/mL LC/MS/MS
Oxycodone Plasma 0.200 ng/mL LC/MS/MS
Oxymorphone Plasma 0.0500 ng/mL LC/MS/MS
Oxymorphone / 6-B-Hydroxyoxymorphone Plasma 0.0500 / 0.0500 ng/mL LC/MS/MS
Oxymorphone / 6-B-Hydroxyoxymorphone (Low Range) Plasma 0.02/0.02-10.0/10.0 ng/mL LC/MS/MS
Oxymorphone / 6-Oxymorphol Plasma 10.0 / 10.0 pg/mL LC/MS/MS


 
 
 
|
|
|
|
|
|
 
Copyright © 2009 CRS Management. All rights reserved.
 
Developed by Web Interactive Technologies Baltimore Web Design